Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Postgrad Med 132(sup2):314 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydn L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
One of these trials also assessed anxiety symptoms and found no effect of liraglutide compared with placebo over 26 weeks in 80 patients with comorbid T2DM and obesity who had previously undergone bariatric surgery 186
How to Introduce GLP-1
Licensed pharmacist-verified supply chain Raw materials verified via HPLC and mass spectrometry to confirm potency and authenticity prior to dispense
